PE-Backed Biotech Co. Egalet Prepares $69M IPO
Venture capital-backed specialty biotechnology company Egalet Corp., which is based in the U.S. but has the bulk of its operations in Denmark, plans to raise up to $69 million in an...To view the full article, register now.
Already a subscriber? Click here to view full article